Apply Now

Eliminating barriers for advancing biomedical science

The Integrated Biomedical Sciences Graduate Program at the University of Notre Dame is a cross-departmental PhD program for research and training in a range of fields in the biomedical sciences. Scientists across the campus, representing 55 different research groups, are organized into thematic Research and Training Clusters that offer students the opportunity to engage in cutting-edge biomedical research that transcends traditional departmental and disciplinary boundaries. Explore our program here, or download a brochure that describes the key aspects.

Recent News

Water discovered to form column of hydration at surface of DNA

Author: Deanna Csomo McCool

Steven Corcelli named ACS Fellow

Scientists have been aware since Watson and Crick first reported the double helix structure of DNA in 1953 that water had an important relationship with the biomolecule. But finally observing the spectroscopic signature of the column of water is a breakthrough with implications for cancer drugs and other biomedical research. Read More

Developing the Gold Standard for Efficient Diagnostics

Author: Brandi Klingerman

Notre Dame researchers are improving the speed and practicality of detecting disease

To detect an illness in the body, common diagnostic tests like the enzyme-linked immunosorbent assay (ELISA) are used. Unfortunately, ELISA takes hours to process and requires expert analysis, limiting its benefits for developing countries and those who require immediate results. In order to combat these challenges, Notre Dame researchers have been working to develop an improved test and have recently published a study on a new diagnostic method that uses gold nanoparticles, requires little to no expertise, and provides results in minutes.

Nur 2Nur Mustafaoglu, a Chemical and Biomolecular Engineering graduate student and Advanced Diagnostics and Therapeutics (AD&T) Berry Family Graduate Fellow Read More

Results of new research on organ transplants can lead to new cancer treatments

Author: Deanna Csomo McCool

Biochemist Brian Baker was struck with an idea for potentially treating cancer when he considered the relationship between a type of treatment being tried on babies with blood cancers, and a molecule that attacked the hepatitis C virus in a liver transplant patient.

Brian Baker 250

Baker, a researcher with the Mike and Josie Harper Cancer Research Institute and the John A. Zahm Professor of Structural Biology, along with graduate students Yuan Wang and Nishant Singh, launched into research with immunologists from Loyola University in Chicago to discover how molecules within T-cells (the subtype of a white blood cell responsible for sensing whether you’re healthy or have an infection) can specifically target certain cells to kill them. Read More